Navamedic
Navamedic ASA, headquartered in Norway, is a prominent player in the pharmaceutical and healthcare industry, specialising in the distribution and marketing of innovative medical products. Founded in 2000, the company has established a strong presence across Europe, focusing on key operational regions such as Scandinavia and the broader European market. Navamedic is renowned for its unique portfolio of products, which includes prescription medicines, over-the-counter drugs, and medical devices. The company distinguishes itself through its commitment to quality and regulatory compliance, ensuring that its offerings meet the highest industry standards. With a solid market position, Navamedic has achieved significant milestones, including strategic partnerships and successful product launches, solidifying its reputation as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Navamedic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Navamedic's score of 38 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Navamedic's reported carbon emissions
In 2023, Navamedic ASA reported total carbon emissions of approximately 76,500 kg CO2e, comprising 16,100 kg CO2e from Scope 1, 800 kg CO2e from Scope 2, and 59,800 kg CO2e from Scope 3, primarily attributed to business travel. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Furthermore, Navamedic is committed to achieving net-zero emissions by 2040, with a target to reduce total emissions across all scopes by 90% from the same baseline year. These targets have been validated by the Science Based Targets initiative (SBTi) and align with the goal of limiting global warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 16,100 |
| Scope 2 | 800 |
| Scope 3 | 59,800 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Navamedic is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
